The Canadian IC device market is a uniquely challenging space characterized by eroding ASPs, an aging population, and an increasing prevalence of complex lesions requiring use of niche devices, such as intravascular imaging catheters and CTO devices.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in Canada across a 10-year period.

Shrinking health care budgets, adoption of tender contracts, and increasing competition will have a significantly impact pricing dynamics in Canada.

What market segments will be the most affected by strong price competition?

How have tender contracts affected market shares in the Canadian IC device market?

How will adoption of premium-priced devices affect ASP declines?

Markets for niche and novel products such as IVUS, FFR, OCT, and premium accessory devices present significant opportunities and will grow the fastest.

To what degree will these devices be adopted given the budget-conscious nature of Canadian facilities and the additional cost associated with their use?

Which market segments have the most potential for growth, and why?

Which segments will attract new competitors?

Highly anticipated BVS and DCBs have finally launched in Canada.

How will the launch of alternatives to metallic coronary stents affect the market?

Will DES penetration rates be diminished by these new technologies?

Will the introduction of DCBs alter the percentage of PCIs that are stented?

Table of contents

  • Interventional Cardiology Devices - Market Insights - Canada

Author(s): Sangeetha Iyer, Pharm.D

Sangeetha Iyer is an analyst within the Cardiovascular Medtech Insights team at Decision Resource Group, specializing in structural heart closure and vascular access device markerts across the Asia Pacific region, as well as medical device pricing and regulations in China and Japan. Sangeetha has represnted India at the European Society of Cardiology confrerence in Greece(2016) and Sweden(2017), where her research poster was awarded the top prize. Sangeetha holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education. Follow Sangeetha on twitter: @Slyer_DRG


Related Reports

Interventional Cardiology Devices - Market Insights - United States

The US IC device market will continue to be negatively affected by policies that contribute to declining ASP

View Details

Interventional Cardiology Devices - Market Insights - Asia Pacific

Although the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020, the Asia Pacific

View Details

Interventional Cardiology Devices - Market Insights - Europe

The mature European IC device market will be limited by declining ASPs due to a number of factors, includ...

View Details

Interventional Cardiology Devices - Market Insights - Japan

The Japanese IC device market is large but mature. Although there is modest procedural growth in

View Details